APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Enzalutamide Drugs Industry Growth and Trends Forecast to 2032

Report ID 173988580127 December 2025111 pages

Choose your research edition.

Industry ResearchEnzalutamide Drugs Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Enzalutamide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Drugs Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Enzalutamide Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Enzalutamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Enzalutamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzalutamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enzalutamide Drugs include Yichang Humanwell Pharmaceutical, Shenyang Hongqi Pharmaceutical, PuraCap Pharmaceuticals, Qilu Pharmaceutical, Kelun Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Zydus, Sun Pharma and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Enzalutamide Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enzalutamide Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enzalutamide Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enzalutamide Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Enzalutamide Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enzalutamide Drugs Market by Company

Yichang Humanwell Pharmaceutical

Shenyang Hongqi Pharmaceutical

PuraCap Pharmaceuticals

Qilu Pharmaceutical

Kelun Pharmaceutical

Jiangsu Hansoh Pharmaceutical

Zydus

Sun Pharma

Pfizer

Intas Pharmaceuticals

Glenmark Pharma

Beacon pharma

BDR Pharma

Astellas Pharma

Arechar Healthcare

Aprazer Healthcare Pharma

Abbott Laboratories

Enzalutamide Drugs Segment by Type

Tablets

Capsules

Enzalutamide Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Enzalutamide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enzalutamide Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Enzalutamide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Capsules Table 3. Global Enzalutamide Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Enzalutamide Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Enzalutamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Enzalutamide Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Enzalutamide Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Enzalutamide Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Enzalutamide Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Enzalutamide Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Enzalutamide Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Enzalutamide Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Enzalutamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Enzalutamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Enzalutamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Enzalutamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Enzalutamide Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Enzalutamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Enzalutamide Drugs Industry Trends Table 25. Enzalutamide Drugs Industry Drivers Table 26. Enzalutamide Drugs Industry Opportunities and Challenges Table 27. Enzalutamide Drugs Industry Restraints Table 28. Global Enzalutamide Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Enzalutamide Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Enzalutamide Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Enzalutamide Drugs Sales Share by Company (2021-2026) Table 32. Global Enzalutamide Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Enzalutamide Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Enzalutamide Drugs Major Company Production Sites and Headquarters Table 35. Global Enzalutamide Drugs Company, Product Type & Application Table 36. Global Enzalutamide Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Enzalutamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Enzalutamide Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Enzalutamide Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Enzalutamide Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Enzalutamide Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Enzalutamide Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Enzalutamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Enzalutamide Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Enzalutamide Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Enzalutamide Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Enzalutamide Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Enzalutamide Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Enzalutamide Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Enzalutamide Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Enzalutamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Enzalutamide Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Enzalutamide Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Enzalutamide Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Enzalutamide Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Enzalutamide Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Enzalutamide Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Enzalutamide Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Enzalutamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Enzalutamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Enzalutamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Enzalutamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Enzalutamide Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Enzalutamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Yichang Humanwell Pharmaceutical Company Information Table 72. Yichang Humanwell Pharmaceutical Business Overview Table 73. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolio Table 75. Yichang Humanwell Pharmaceutical Recent Development Table 76. Shenyang Hongqi Pharmaceutical Company Information Table 77. Shenyang Hongqi Pharmaceutical Business Overview Table 78. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolio Table 80. Shenyang Hongqi Pharmaceutical Recent Development Table 81. PuraCap Pharmaceuticals Company Information Table 82. PuraCap Pharmaceuticals Business Overview Table 83. PuraCap Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolio Table 85. PuraCap Pharmaceuticals Recent Development Table 86. Qilu Pharmaceutical Company Information Table 87. Qilu Pharmaceutical Business Overview Table 88. Qilu Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Qilu Pharmaceutical Enzalutamide Drugs Product Portfolio Table 90. Qilu Pharmaceutical Recent Development Table 91. Kelun Pharmaceutical Company Information Table 92. Kelun Pharmaceutical Business Overview Table 93. Kelun Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Kelun Pharmaceutical Enzalutamide Drugs Product Portfolio Table 95. Kelun Pharmaceutical Recent Development Table 96. Jiangsu Hansoh Pharmaceutical Company Information Table 97. Jiangsu Hansoh Pharmaceutical Business Overview Table 98. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolio Table 100. Jiangsu Hansoh Pharmaceutical Recent Development Table 101. Zydus Company Information Table 102. Zydus Business Overview Table 103. Zydus Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Zydus Enzalutamide Drugs Product Portfolio Table 105. Zydus Recent Development Table 106. Sun Pharma Company Information Table 107. Sun Pharma Business Overview Table 108. Sun Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sun Pharma Enzalutamide Drugs Product Portfolio Table 110. Sun Pharma Recent Development Table 111. Pfizer Company Information Table 112. Pfizer Business Overview Table 113. Pfizer Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Pfizer Enzalutamide Drugs Product Portfolio Table 115. Pfizer Recent Development Table 116. Intas Pharmaceuticals Company Information Table 117. Intas Pharmaceuticals Business Overview Table 118. Intas Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Intas Pharmaceuticals Enzalutamide Drugs Product Portfolio Table 120. Intas Pharmaceuticals Recent Development Table 121. Glenmark Pharma Company Information Table 122. Glenmark Pharma Business Overview Table 123. Glenmark Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Glenmark Pharma Enzalutamide Drugs Product Portfolio Table 125. Glenmark Pharma Recent Development Table 126. Beacon pharma Company Information Table 127. Beacon pharma Business Overview Table 128. Beacon pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Beacon pharma Enzalutamide Drugs Product Portfolio Table 130. Beacon pharma Recent Development Table 131. BDR Pharma Company Information Table 132. BDR Pharma Business Overview Table 133. BDR Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. BDR Pharma Enzalutamide Drugs Product Portfolio Table 135. BDR Pharma Recent Development Table 136. Astellas Pharma Company Information Table 137. Astellas Pharma Business Overview Table 138. Astellas Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Astellas Pharma Enzalutamide Drugs Product Portfolio Table 140. Astellas Pharma Recent Development Table 141. Arechar Healthcare Company Information Table 142. Arechar Healthcare Business Overview Table 143. Arechar Healthcare Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Arechar Healthcare Enzalutamide Drugs Product Portfolio Table 145. Arechar Healthcare Recent Development Table 146. Aprazer Healthcare Pharma Company Information Table 147. Aprazer Healthcare Pharma Business Overview Table 148. Aprazer Healthcare Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolio Table 150. Aprazer Healthcare Pharma Recent Development Table 151. Abbott Laboratories Company Information Table 152. Abbott Laboratories Business Overview Table 153. Abbott Laboratories Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Abbott Laboratories Enzalutamide Drugs Product Portfolio Table 155. Abbott Laboratories Recent Development Table 156. North America Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 158. North America Enzalutamide Drugs Sales Market Share by Country (2021-2026) Table 159. North America Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Enzalutamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. North America Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Enzalutamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Enzalutamide Drugs Market Share by Country (2021-2026) Table 164. North America Enzalutamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Enzalutamide Drugs Market Share Forecast by Country (2027-2032) Table 166. Europe Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 168. Europe Enzalutamide Drugs Sales Market Share by Country (2021-2026) Table 169. Europe Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Enzalutamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Enzalutamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Enzalutamide Drugs Market Share by Country (2021-2026) Table 174. Europe Enzalutamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Enzalutamide Drugs Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Enzalutamide Drugs Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Enzalutamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Enzalutamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Enzalutamide Drugs Market Share by Country (2021-2026) Table 184. Asia-Pacific Enzalutamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Enzalutamide Drugs Market Share Forecast by Country (2027-2032) Table 186. Latin America Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 188. Latin America Enzalutamide Drugs Sales Market Share by Country (2021-2026) Table 189. Latin America Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Enzalutamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Enzalutamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Enzalutamide Drugs Market Share by Country (2021-2026) Table 194. Latin America Enzalutamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Enzalutamide Drugs Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Enzalutamide Drugs Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Enzalutamide Drugs Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Enzalutamide Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Enzalutamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Enzalutamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Enzalutamide Drugs Market Share by Country (2021-2026) Table 204. Middle East and Africa Enzalutamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Enzalutamide Drugs Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Enzalutamide Drugs Distributors List Table 209. Enzalutamide Drugs Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Enzalutamide Drugs Image Figure 2. Global Enzalutamide Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzalutamide Drugs Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Enzalutamide Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Enzalutamide Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Enzalutamide Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Enzalutamide Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Enzalutamide Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Enzalutamide Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Enzalutamide Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Enzalutamide Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Enzalutamide Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Enzalutamide Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Enzalutamide Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Enzalutamide Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Enzalutamide Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Enzalutamide Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Enzalutamide Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Enzalutamide Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Enzalutamide Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Enzalutamide Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Enzalutamide Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Enzalutamide Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Enzalutamide Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Enzalutamide Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Enzalutamide Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Enzalutamide Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Enzalutamide Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Enzalutamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Enzalutamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Enzalutamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Enzalutamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Enzalutamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Enzalutamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Enzalutamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Enzalutamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Enzalutamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Enzalutamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Enzalutamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Enzalutamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Enzalutamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Enzalutamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Enzalutamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Enzalutamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Enzalutamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Enzalutamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Enzalutamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Enzalutamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Enzalutamide Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Enzalutamide Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Yichang Humanwell Pharmaceutical
  • Shenyang Hongqi Pharmaceutical
  • PuraCap Pharmaceuticals
  • Qilu Pharmaceutical
  • Kelun Pharmaceutical
  • Jiangsu Hansoh Pharmaceutical
  • Zydus
  • Sun Pharma
  • Pfizer
  • Intas Pharmaceuticals
  • Glenmark Pharma
  • Beacon pharma
  • BDR Pharma
  • Astellas Pharma
  • Arechar Healthcare
  • Aprazer Healthcare Pharma
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enzalutamide Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Enzalutamide Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Enzalutamide Drugs Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Capsules
  8. 1.4 Global Enzalutamide Drugs Market Size by Type
  9. 1.4.1 Global Enzalutamide Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Enzalutamide Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Enzalutamide Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Enzalutamide Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Enzalutamide Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Enzalutamide Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Enzalutamide Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Enzalutamide Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Enzalutamide Drugs Industry Trends
  2. 2.2 Enzalutamide Drugs Industry Drivers
  3. 2.3 Enzalutamide Drugs Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Enzalutamide Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Enzalutamide Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Enzalutamide Drugs Price (2021-2026)
  4. 3.4 Global Enzalutamide Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enzalutamide Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Enzalutamide Drugs Company, Product Type & Application
  7. 3.7 Global Enzalutamide Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enzalutamide Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enzalutamide Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enzalutamide Drugs Tier 1, Tier 2, and Tier 3
4 Enzalutamide Drugs Regional Status and Outlook
  1. 4.1 Global Enzalutamide Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Enzalutamide Drugs Historic Market Size by Region
  3. 4.2.1 Global Enzalutamide Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Enzalutamide Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Enzalutamide Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Enzalutamide Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Enzalutamide Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Enzalutamide Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Enzalutamide Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Enzalutamide Drugs by Application
  1. 5.1 Enzalutamide Drugs Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Enzalutamide Drugs Market Size by Application
  6. 5.2.1 Global Enzalutamide Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Enzalutamide Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Enzalutamide Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Enzalutamide Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Enzalutamide Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Enzalutamide Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Enzalutamide Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Enzalutamide Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yichang Humanwell Pharmaceutical
  2. 6.1.1 Yichang Humanwell Pharmaceutical Company Information
  3. 6.1.2 Yichang Humanwell Pharmaceutical Business Overview
  4. 6.1.3 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolio
  6. 6.1.5 Yichang Humanwell Pharmaceutical Recent Developments
  7. 6.2 Shenyang Hongqi Pharmaceutical
  8. 6.2.1 Shenyang Hongqi Pharmaceutical Company Information
  9. 6.2.2 Shenyang Hongqi Pharmaceutical Business Overview
  10. 6.2.3 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolio
  12. 6.2.5 Shenyang Hongqi Pharmaceutical Recent Developments
  13. 6.3 PuraCap Pharmaceuticals
  14. 6.3.1 PuraCap Pharmaceuticals Company Information
  15. 6.3.2 PuraCap Pharmaceuticals Business Overview
  16. 6.3.3 PuraCap Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolio
  18. 6.3.5 PuraCap Pharmaceuticals Recent Developments
  19. 6.4 Qilu Pharmaceutical
  20. 6.4.1 Qilu Pharmaceutical Company Information
  21. 6.4.2 Qilu Pharmaceutical Business Overview
  22. 6.4.3 Qilu Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Qilu Pharmaceutical Enzalutamide Drugs Product Portfolio
  24. 6.4.5 Qilu Pharmaceutical Recent Developments
  25. 6.5 Kelun Pharmaceutical
  26. 6.5.1 Kelun Pharmaceutical Company Information
  27. 6.5.2 Kelun Pharmaceutical Business Overview
  28. 6.5.3 Kelun Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kelun Pharmaceutical Enzalutamide Drugs Product Portfolio
  30. 6.5.5 Kelun Pharmaceutical Recent Developments
  31. 6.6 Jiangsu Hansoh Pharmaceutical
  32. 6.6.1 Jiangsu Hansoh Pharmaceutical Company Information
  33. 6.6.2 Jiangsu Hansoh Pharmaceutical Business Overview
  34. 6.6.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolio
  36. 6.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  37. 6.7 Zydus
  38. 6.7.1 Zydus Company Information
  39. 6.7.2 Zydus Business Overview
  40. 6.7.3 Zydus Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zydus Enzalutamide Drugs Product Portfolio
  42. 6.7.5 Zydus Recent Developments
  43. 6.8 Sun Pharma
  44. 6.8.1 Sun Pharma Company Information
  45. 6.8.2 Sun Pharma Business Overview
  46. 6.8.3 Sun Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharma Enzalutamide Drugs Product Portfolio
  48. 6.8.5 Sun Pharma Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Enzalutamide Drugs Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Intas Pharmaceuticals
  56. 6.10.1 Intas Pharmaceuticals Company Information
  57. 6.10.2 Intas Pharmaceuticals Business Overview
  58. 6.10.3 Intas Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Intas Pharmaceuticals Enzalutamide Drugs Product Portfolio
  60. 6.10.5 Intas Pharmaceuticals Recent Developments
  61. 6.11 Glenmark Pharma
  62. 6.11.1 Glenmark Pharma Company Information
  63. 6.11.2 Glenmark Pharma Business Overview
  64. 6.11.3 Glenmark Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Glenmark Pharma Enzalutamide Drugs Product Portfolio
  66. 6.11.5 Glenmark Pharma Recent Developments
  67. 6.12 Beacon pharma
  68. 6.12.1 Beacon pharma Company Information
  69. 6.12.2 Beacon pharma Business Overview
  70. 6.12.3 Beacon pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Beacon pharma Enzalutamide Drugs Product Portfolio
  72. 6.12.5 Beacon pharma Recent Developments
  73. 6.13 BDR Pharma
  74. 6.13.1 BDR Pharma Company Information
  75. 6.13.2 BDR Pharma Business Overview
  76. 6.13.3 BDR Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 BDR Pharma Enzalutamide Drugs Product Portfolio
  78. 6.13.5 BDR Pharma Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Astellas Pharma Enzalutamide Drugs Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 Arechar Healthcare
  86. 6.15.1 Arechar Healthcare Company Information
  87. 6.15.2 Arechar Healthcare Business Overview
  88. 6.15.3 Arechar Healthcare Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Arechar Healthcare Enzalutamide Drugs Product Portfolio
  90. 6.15.5 Arechar Healthcare Recent Developments
  91. 6.16 Aprazer Healthcare Pharma
  92. 6.16.1 Aprazer Healthcare Pharma Company Information
  93. 6.16.2 Aprazer Healthcare Pharma Business Overview
  94. 6.16.3 Aprazer Healthcare Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolio
  96. 6.16.5 Aprazer Healthcare Pharma Recent Developments
  97. 6.17 Abbott Laboratories
  98. 6.17.1 Abbott Laboratories Company Information
  99. 6.17.2 Abbott Laboratories Business Overview
  100. 6.17.3 Abbott Laboratories Enzalutamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Abbott Laboratories Enzalutamide Drugs Product Portfolio
  102. 6.17.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Enzalutamide Drugs Sales by Country
  2. 7.1.1 North America Enzalutamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Enzalutamide Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Enzalutamide Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Enzalutamide Drugs Market Size by Country
  6. 7.2.1 North America Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Enzalutamide Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Enzalutamide Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Enzalutamide Drugs Sales by Country
  2. 8.1.1 Europe Enzalutamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Enzalutamide Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Enzalutamide Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Enzalutamide Drugs Market Size by Country
  6. 8.2.1 Europe Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Enzalutamide Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Enzalutamide Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Enzalutamide Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Enzalutamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Enzalutamide Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Enzalutamide Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Enzalutamide Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Enzalutamide Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Enzalutamide Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Enzalutamide Drugs Sales by Country
  2. 10.1.1 South America Enzalutamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Enzalutamide Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Enzalutamide Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Enzalutamide Drugs Market Size by Country
  6. 10.2.1 South America Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Enzalutamide Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Enzalutamide Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Enzalutamide Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Enzalutamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Enzalutamide Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Enzalutamide Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Enzalutamide Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Enzalutamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Enzalutamide Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Enzalutamide Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Enzalutamide Drugs Value Chain Analysis
  2. 12.1.1 Enzalutamide Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Enzalutamide Drugs Production Mode & Process
  7. 12.2 Enzalutamide Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Enzalutamide Drugs Distributors
  10. 12.2.3 Enzalutamide Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst